Skip to main content

WPI 3704 Pill - white capsule/oblong, 14mm

Pill with imprint WPI 3704 is White, Capsule/Oblong and has been identified as Armodafinil 200 mg. It is supplied by Watson Laboratories, Inc.

Armodafinil is used in the treatment of Narcolepsy; Shift Work Sleep Disorder; Obstructive Sleep Apnea/Hypopnea Syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3704

Armodafinil

Imprint
WPI 3704
Strength
200 mg
Color
White
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3704
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromelloses, magnesium stearate, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.